|
|
|
Insider
Information: |
Knight Peter S |
Relationship: |
Director |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
214,385 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$226,586 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
214,385 |
|
|
Total
Value |
$226,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Casi Pharmaceuticals Inc |
CASI |
Director |
2008-06-05 |
139,010 |
2003-10-21 |
0 |
Premium* |
|
Par Pharmaceutical Companies Inc |
PRX |
Director |
2012-09-28 |
0 |
2004-05-04 |
0 |
Premium* |
|
Medicis Pharmaceutical Corp |
MRX |
|
2012-12-11 |
0 |
2004-02-18 |
0 |
Premium* |
|
Bioaffinity Technologies, Inc. |
BIAF |
Director |
2024-01-01 |
75,375 |
2022-08-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRX |
Medicis Pharmaceutical Co... |
|
|
2011-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,411 |
10,221 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2011-05-19 |
4 |
S |
$37.09 |
$1,149,852 |
D/D |
(31,000) |
10,221 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2011-05-19 |
4 |
OE |
$20.44 |
$729,190 |
D/D |
31,000 |
41,221 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2012-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,311 |
12,532 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2012-08-23 |
4 |
S |
$32.16 |
$112,560 |
D/D |
(3,500) |
12,532 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2012-08-23 |
4 |
OE |
$20.44 |
$71,540 |
D/D |
3,500 |
16,032 |
0 |
- |
|
MRX |
Medicis Pharmaceutical Co... |
|
|
2012-12-11 |
4 |
D |
$44.00 |
$551,408 |
D/D |
(12,532) |
0 |
0 |
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2003-10-21 |
4 |
A |
$5.49 |
$24,996 |
D/D |
4,553 |
4,553 |
|
- |
|
MRX |
Medicis Pharmaceutical Co... |
Director |
|
2004-02-18 |
4 |
OE |
$14.25 |
$488,100 |
D/D |
30,000 |
0 |
|
- |
|
MRX |
Medicis Pharmaceutical Co... |
Director |
|
2004-02-18 |
4 |
S |
$40.28 |
$1,208,400 |
D/D |
(30,000) |
7,810 |
|
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2004-05-04 |
4 |
B |
$40.74 |
$40,740 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2004-06-16 |
4 |
A |
$2.16 |
$25,000 |
D/D |
11,574 |
16,127 |
|
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2005-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2005-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,064 |
24,191 |
|
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2006-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,025 |
40,216 |
|
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2007-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,500 |
0 |
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2007-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,481 |
68,697 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2007-10-25 |
4 |
B |
$18.08 |
$45,230 |
D/D |
2,500 |
3,500 |
2.39 |
- |
|
CASI |
Casi Pharmaceuticals Inc |
Director |
|
2008-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
70,313 |
139,010 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2011-12-15 |
4 |
OE |
$29.90 |
$74,750 |
D/D |
2,500 |
6,000 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2011-12-15 |
4 |
S |
$32.51 |
$81,284 |
D/D |
(2,500) |
3,500 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2012-03-19 |
4 |
S |
$37.01 |
$277,675 |
D/D |
(7,500) |
3,500 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2012-03-19 |
4 |
OE |
$28.79 |
$215,925 |
D/D |
7,500 |
11,000 |
0 |
- |
|
PRX |
Par Pharmaceutical Compan... |
Director |
|
2012-09-28 |
4 |
D |
$50.00 |
$175,000 |
D/D |
(3,500) |
0 |
0 |
- |
|
BIAF |
Bioaffinity Technologies,... |
Director |
|
2022-08-31 |
4 |
B |
$0.00 |
$0 |
D/D |
8,163 |
22,448 |
2.31 |
- |
|
34 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|